Collection of blood samples from adults with brain tumors
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
This study is collecting blood samples from adults with brain tumors to see if certain markers in the blood can help improve treatment outcomes after radiation therapy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Duke University Academic / other |
| Drugs / interventions | Radiation |
| Locations | 1 site (Durham, North Carolina) |
| Trial ID | NCT05480644 on ClinicalTrials.gov |
What this trial studies
This study aims to create a repository of blood samples from adults diagnosed with primary and metastatic brain tumors at the Duke Cancer Center. The collected samples will be analyzed to investigate the relationship between circulating biomarkers and the outcomes of radiation therapy. By understanding these associations, the study seeks to enhance treatment strategies for patients with brain tumors. The observational nature of the study allows for the collection of valuable data without any specified interventions.
Who should consider this trial
Good fit: Ideal candidates for this study are adults who have a confirmed diagnosis of primary or metastatic brain tumors.
Not a fit: Patients without a confirmed diagnosis of brain tumors will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment outcomes for patients with brain tumors by identifying biomarkers that predict responses to radiation therapy.
How similar studies have performed: Other studies have shown promise in using circulating biomarkers to predict treatment outcomes in various cancers, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have a confirmed diagnosis of primary or metastatic brain tumor (histology or imaging as appropriate) Exclusion Criteria: * None
Where this trial is running
Durham, North Carolina
- Duke Cancer Center — Durham, North Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Eugene Vaios, MD MBA — Duke University Health System (DUHS)
- Study coordinator: Kaitlin Bailey, RN OCN
- Email: Kaitlin.Bailey@duke.edu
- Phone: (919) 668-3726
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.